Prof. Dr. med. Markus Heim0 minute read You May Also Like View Post 12 min Cancer prevention Constant dripping – alcohol and cancer CME continuing education General Internal Medicine Oncology Pharmacology and toxicology Prevention and health care Psychiatry and psychotherapy RX Studies View Post 7 min Steatotic liver disease GLP-1RA in MASH – what’s new? Congress Reports Endocrinology and Diabetology Gastroenterology and Hepatology General Internal Medicine Pharmacology and toxicology RX Studies View Post 6 min Chronic pruritus: “Tour d'horizon” Focus on new anti-inflammatory therapeutic approaches Allergology and clinical immunology Congress Reports Dermatology and venereology Pharmacology and toxicology RX Studies View Post 5 min Multiple sclerosis Unexpected side effects when switching from natalizumab to a biosimilar Education Neurology Pharmacology and toxicology RX Studies View Post 3 min "Patients W.A.I.T. Indicator" Access to new drugs is becoming increasingly difficult Oncology Pharmacology and toxicology Practice Management RX Studies View Post 3 min Immunotherapy Subcutaneously or intravenously? Congress Reports Oncology Pneumology RX Studies View Post 4 min Work-related asthma When the job leads to exacerbations Allergology and clinical immunology Education General Internal Medicine Pneumology RX Studies View Post 8 min ASCO 2025 Supportive therapies for greater adherence and compliance Congress Reports Hematology Oncology RX Studies
View Post 12 min Cancer prevention Constant dripping – alcohol and cancer CME continuing education General Internal Medicine Oncology Pharmacology and toxicology Prevention and health care Psychiatry and psychotherapy RX Studies
View Post 7 min Steatotic liver disease GLP-1RA in MASH – what’s new? Congress Reports Endocrinology and Diabetology Gastroenterology and Hepatology General Internal Medicine Pharmacology and toxicology RX Studies
View Post 6 min Chronic pruritus: “Tour d'horizon” Focus on new anti-inflammatory therapeutic approaches Allergology and clinical immunology Congress Reports Dermatology and venereology Pharmacology and toxicology RX Studies
View Post 5 min Multiple sclerosis Unexpected side effects when switching from natalizumab to a biosimilar Education Neurology Pharmacology and toxicology RX Studies
View Post 3 min "Patients W.A.I.T. Indicator" Access to new drugs is becoming increasingly difficult Oncology Pharmacology and toxicology Practice Management RX Studies
View Post 3 min Immunotherapy Subcutaneously or intravenously? Congress Reports Oncology Pneumology RX Studies
View Post 4 min Work-related asthma When the job leads to exacerbations Allergology and clinical immunology Education General Internal Medicine Pneumology RX Studies
View Post 8 min ASCO 2025 Supportive therapies for greater adherence and compliance Congress Reports Hematology Oncology RX Studies
